
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $124.6M | $211.9M | $181.8M | $163M | $189.6M | |
Revenue Growth (YoY) | 50.23% | 70.08% | -14.21% | -10.36% | 16.35% | |
Cost of Revenues | $48M | $83M | $74M | $60.7M | $67.8M | |
Gross Profit | $76.6M | $129M | $107.8M | $102.2M | $121.9M | |
Gross Profit Margin | 61.48% | 60.86% | 59.31% | 62.74% | 64.27% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $15.5M | $21.4M | $20.2M | $20.6M | $28.5M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $51.1M | $73.8M | $70.3M | $66.5M | $83.5M | |
Operating Income | $25.6M | $55.2M | $37.6M | $35.8M | $38.4M | |
Net Interest Expenses | $2.8M | $2.5M | $2M | $3.1M | $3.3M | |
EBT. Incl. Unusual Items | $23.2M | $53.5M | $38.8M | $32M | $34.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $5M | $12.3M | $9.2M | $6.8M | $8.3M | |
Net Income to Company | $23.2M | $53.5M | $38.8M | $32M | $34.5M | |
Minority Interest in Earnings | -$543.6K | -$1.3M | -$1M | -$10.8K | -- | |
Net Income to Common Excl Extra Items | $17.7M | $39.8M | $28.6M | $25.2M | $26.2M | |
Basic EPS (Cont. Ops) | $0.95 | $2.13 | $1.53 | $1.35 | $1.41 | |
Diluted EPS (Cont. Ops) | $0.94 | $2.12 | $1.52 | $1.34 | $1.40 | |
Weighted Average Basic Share | $18.7M | $18.7M | $18.7M | $18.7M | $18.7M | |
Weighted Average Diluted Share | $18.9M | $18.8M | $18.8M | $18.8M | $18.8M | |
EBITDA | $29.3M | $61.8M | $47.8M | $41.7M | $45.7M | |
EBIT | $24.4M | $54.9M | $39.9M | $34.9M | $38.2M | |
Revenue (Reported) | $124.6M | $211.9M | $181.8M | $163M | $189.6M | |
Operating Income (Reported) | $25.6M | $55.2M | $37.6M | $35.8M | $38.4M | |
Operating Income (Adjusted) | $24.4M | $54.9M | $39.9M | $34.9M | $38.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $47.8M | $57M | $44.4M | $46M | $54.7M | |
Revenue Growth (YoY) | 112.49% | 19.41% | -22.07% | 3.5% | 18.88% | |
Cost of Revenues | $18.3M | $23.7M | $17.1M | $16.3M | $18.5M | |
Gross Profit | $29.5M | $33.3M | $27.4M | $29.7M | $36.2M | |
Gross Profit Margin | 61.67% | 58.38% | 61.54% | 64.61% | 66.22% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $16.1M | $19.7M | $17.5M | $19M | $23.7M | |
Operating Income | $13.3M | $13.6M | $9.9M | $10.7M | $12.5M | |
Net Interest Expenses | $365.1K | $455.6K | $859.2K | $546.4K | $1.5M | |
EBT. Incl. Unusual Items | $13.1M | $14.4M | $8.9M | $10.6M | $11.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.9M | $3.5M | $2.2M | $2.5M | $2.3M | |
Net Income to Company | $13.1M | $14.4M | $8.9M | $10.6M | $11.1M | |
Minority Interest in Earnings | -$283.2K | -$461.2K | -$2.2K | -- | -- | |
Net Income to Common Excl Extra Items | $9.9M | $10.4M | $6.7M | $8.1M | $8.8M | |
Basic EPS (Cont. Ops) | $0.53 | $0.56 | $0.37 | $0.43 | $0.47 | |
Diluted EPS (Cont. Ops) | $0.53 | $0.55 | $0.35 | $0.43 | $0.47 | |
Weighted Average Basic Share | $18.6M | $18.6M | $18.7M | $18.7M | $18.7M | |
Weighted Average Diluted Share | $18.9M | $18.7M | $18.8M | $18.8M | $18.8M | |
EBITDA | $15.4M | $17M | $11.6M | $13.4M | $14.8M | |
EBIT | $13.9M | $15.2M | $9.9M | $11.7M | $12.8M | |
Revenue (Reported) | $47.8M | $57M | $44.4M | $46M | $54.7M | |
Operating Income (Reported) | $13.3M | $13.6M | $9.9M | $10.7M | $12.5M | |
Operating Income (Adjusted) | $13.9M | $15.2M | $9.9M | $11.7M | $12.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $150.6M | $221.1M | $170.2M | $164.4M | $198.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $57.7M | $88.3M | $67.8M | $59.9M | $69.8M | |
Gross Profit | $93M | $132.7M | $102.4M | $104.6M | $128.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $57.2M | $77.3M | $68.1M | $68M | $88.1M | |
Operating Income | $35.7M | $55.5M | $34.2M | $36.6M | $40.2M | |
Net Interest Expenses | $2.7M | $2.3M | $1.9M | $3.3M | $4.3M | |
EBT. Incl. Unusual Items | $33.3M | $54.8M | $33.7M | $33.7M | $34.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $7.3M | $13M | $7.9M | $7.1M | $8M | |
Net Income to Company | $33M | $54.8M | $33.3M | $33.7M | $35M | |
Minority Interest in Earnings | -$841.1K | -$1.5M | -$605K | -$7.6K | -- | |
Net Income to Common Excl Extra Items | $25.1M | $40.4M | $25.2M | $26.6M | $26.9M | |
Basic EPS (Cont. Ops) | $1.34 | $2.17 | $1.36 | $1.42 | $1.44 | |
Diluted EPS (Cont. Ops) | $1.33 | $2.14 | $1.33 | $1.41 | $1.44 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $42.2M | $65.2M | $45.3M | $44.8M | $48.4M | |
EBIT | $36.6M | $57.9M | $37.6M | $38M | $40.6M | |
Revenue (Reported) | $150.6M | $221.1M | $170.2M | $164.4M | $198.1M | |
Operating Income (Reported) | $35.7M | $55.5M | $34.2M | $36.6M | $40.2M | |
Operating Income (Adjusted) | $36.6M | $57.9M | $37.6M | $38M | $40.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $47.8M | $57M | $44.4M | $46M | $54.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $18.3M | $23.7M | $17.1M | $16.3M | $18.5M | |
Gross Profit | $29.5M | $33.3M | $27.4M | $29.7M | $36.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $16.1M | $19.7M | $17.5M | $19M | $23.7M | |
Operating Income | $13.3M | $13.6M | $9.9M | $10.7M | $12.5M | |
Net Interest Expenses | $365.1K | $455.6K | $859.2K | $546.4K | $1.5M | |
EBT. Incl. Unusual Items | $13.1M | $14.4M | $8.9M | $10.6M | $11.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.9M | $3.5M | $2.2M | $2.5M | $2.3M | |
Net Income to Company | $13.1M | $14.4M | $8.9M | $10.6M | $11.1M | |
Minority Interest in Earnings | -$283.2K | -$461.2K | -$2.2K | -- | -- | |
Net Income to Common Excl Extra Items | $9.9M | $10.4M | $6.7M | $8.1M | $8.8M | |
Basic EPS (Cont. Ops) | $0.53 | $0.56 | $0.37 | $0.43 | $0.47 | |
Diluted EPS (Cont. Ops) | $0.53 | $0.55 | $0.35 | $0.43 | $0.47 | |
Weighted Average Basic Share | $18.6M | $18.6M | $18.7M | $18.7M | $18.7M | |
Weighted Average Diluted Share | $18.9M | $18.7M | $18.8M | $18.8M | $18.8M | |
EBITDA | $15.4M | $17M | $11.6M | $13.4M | $14.8M | |
EBIT | $13.9M | $15.2M | $9.9M | $11.7M | $12.8M | |
Revenue (Reported) | $47.8M | $57M | $44.4M | $46M | $54.7M | |
Operating Income (Reported) | $13.3M | $13.6M | $9.9M | $10.7M | $12.5M | |
Operating Income (Adjusted) | $13.9M | $15.2M | $9.9M | $11.7M | $12.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $33.6M | $17.5M | $27.1M | $44.9M | $48.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $14.5M | $18.4M | $17.6M | $18.1M | $20M | |
Inventory | $25.5M | $52.2M | $48.6M | $39.2M | $51.1M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $1.2K | -$1.1K | $1.1K | -- | $37.5K | |
Total Current Assets | $77.1M | $93M | $96.9M | $109.9M | $123.3M | |
Property Plant And Equipment | $24.1M | $34.7M | $31.4M | $32.5M | $37.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $87.3M | $83.5M | $78.8M | $81.1M | $94.7M | |
Other Intangibles | $12.8M | $14.4M | $11.2M | $9.6M | $17.6M | |
Other Long-Term Assets | $1.2K | -- | $2.2K | $28.7K | -$1K | |
Total Assets | $203.7M | $228.1M | $223.9M | $236.8M | $275.2M | |
Accounts Payable | $10.4M | $13.3M | $9.4M | $9.6M | $13.6M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $496.9K | $636.3K | $615.6K | $840.1K | $989.6K | |
Other Current Liabilities | $2.3M | $3.8M | $1.3M | $1.7M | $2.2M | |
Total Current Liabilities | $27.6M | $36.7M | $27.6M | $27.5M | $30.4M | |
Long-Term Debt | $69.3M | $63.8M | $80.8M | $83.4M | $99.3M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $119M | $132.9M | $118.5M | $116.7M | $146.1M | |
Common Stock | $98.4K | $90.6K | $85.8K | $88.4K | $83.3K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $81.7M | $91.2M | $104.3M | $118.9M | $127.8M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $3M | $4.1M | $1.1M | $1.2M | $1.3M | |
Total Equity | $84.7M | $95.3M | $105.5M | $120.1M | $129.1M | |
Total Liabilities and Equity | $203.7M | $228.1M | $223.9M | $236.8M | $275.2M | |
Cash and Short Terms | $33.6M | $17.5M | $27.1M | $44.9M | $48.3M | |
Total Debt | $69.3M | $63.9M | $83M | $83.4M | $99.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $38.1M | $19.9M | $34.8M | $55.6M | $57.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $21.4M | $24.8M | $20.2M | $23M | $24M | |
Inventory | $28.4M | $57.6M | $44.9M | $38.1M | $53.6M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $1.2K | -- | -$1.1K | -- | -- | |
Total Current Assets | $88.1M | $106.9M | $103.2M | $117.3M | $139M | |
Property Plant And Equipment | $24M | $34M | $31.1M | $32.9M | $39M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $83.2M | $82.3M | $80.1M | $79.3M | $97.7M | |
Other Intangibles | $12.1M | $13.7M | $10.9M | $8.8M | $18.6M | |
Other Long-Term Assets | -$1.2K | $1.1K | -- | $1.1K | -- | |
Total Assets | $209.7M | $240.1M | $230.9M | $242.2M | $296.5M | |
Accounts Payable | $25.2M | $17.1M | $9.1M | $23.5M | $17.4M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $589.7K | $590.4K | $549.6K | $628.5K | $1.2M | |
Other Current Liabilities | $1.2K | -- | -$1.1K | $186.8K | $1.1K | |
Total Current Liabilities | $31.5M | $41M | $25.2M | $29.1M | $35.6M | |
Long-Term Debt | $66.1M | $62.9M | $82.2M | $81.4M | $103.3M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $118.4M | $136.9M | $117.5M | $116M | $155.7M | |
Common Stock | $93.8K | $89.3K | $87.2K | $86.4K | $86.6K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $3.1M | $4.4M | $1.2M | $1.3M | $1.3M | |
Total Equity | $91.3M | $103.2M | $113.4M | $126.2M | $140.8M | |
Total Liabilities and Equity | $209.7M | $240.1M | $230.9M | $242.2M | $296.5M | |
Cash and Short Terms | $38.1M | $19.9M | $34.8M | $55.6M | $57.1M | |
Total Debt | $66.1M | $62.9M | $82.2M | $81.4M | $103.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $23.2M | $53.5M | $38.8M | $32M | $34.5M | |
Depreciation & Amoritzation | $4.9M | $6.9M | $7.9M | $6.8M | $7.6M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $856.5K | -$2.4M | $522K | -$1.5M | -$637.5K | |
Change in Inventories | -$2.8M | -$26.7M | -$898.5K | $10.9M | -$9.5M | |
Cash From Operations | $32.1M | $25.8M | $25.7M | $42.4M | $34.3M | |
Capital Expenditures | $2.9M | $13.9M | $3.8M | $3.4M | $6.7M | |
Cash Acquisitions | -$20.6M | -$8.9M | $109.7K | -$3M | -$26.9M | |
Cash From Investing | -$23.5M | -$22.7M | -$3.6M | -$6.3M | -$32.5M | |
Dividends Paid (Ex Special Dividend) | -$8.1M | -$11.3M | -$11.9M | -$12.9M | -$13.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $22.8M | $66.8M | $22.1M | $1M | $21.6M | |
Long-Term Debt Repaid | -$72K | -- | -- | -- | -- | |
Repurchase of Common Stock | -$1.2M | -$3M | -$329K | -- | -- | |
Other Financing Activities | $1.1K | -$67.3M | -$20.2M | -$3.1M | $76.9K | |
Cash From Financing | $10.2M | -$17.4M | -$11.9M | -$19M | $4M | |
Beginning Cash (CF) | $12.4M | $32.3M | $16.3M | $27.4M | $43.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $18.7M | -$14.3M | $10.1M | $17M | $5.8M | |
Ending Cash (CF) | $31.2M | $18.3M | $26.7M | $43.9M | $50.3M | |
Levered Free Cash Flow | $29.1M | $11.9M | $21.9M | $39M | $27.6M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $14.9M | $9.7M | $7.7M | $8.4M | -- | |
Depreciation & Amoritzation | $1.7M | $1.7M | $1.7M | $1.7M | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$3.5M | $3.1M | $629.3K | -$2.6M | -- | |
Change in Inventories | -$7.4M | -$2M | $469.1K | -$3.6M | -- | |
Cash From Operations | $5.7M | -$142.3K | $8.6M | $1.2M | -- | |
Capital Expenditures | $4.9M | $1.2M | $950.3K | $570K | -- | |
Cash Acquisitions | -$6.3M | -- | -- | -- | -- | |
Cash From Investing | -$11.2M | -$1.1M | -$853.2K | -$562.4K | -- | |
Dividends Paid (Ex Special Dividend) | -$7.2M | -$6M | -$6.5M | -$6.8M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -$19.3K | $4.3M | -- | $1.1K | -- | |
Long-Term Debt Repaid | -- | $4.5K | -$41.6K | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$2.4K | -$11.3K | -$41.6K | -$5.3K | -- | |
Cash From Financing | -$8M | -$1.7M | -$7.6M | -$7.6M | -- | |
Beginning Cash (CF) | $39.2M | $20M | $34.3M | $56M | -- | |
Foreign Exchange Rate Adjustment | -$12K | $927.1K | -$280.3K | $212K | -- | |
Additions / Reductions | -$13.4M | -$3M | $188.9K | -$6.9M | -- | |
Ending Cash (CF) | $25.8M | $17.1M | $34.6M | $48.9M | -- | |
Levered Free Cash Flow | $819.2K | -$1.3M | $7.7M | $641.8K | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $33M | $54.8M | $33.3M | $33.7M | $35M | |
Depreciation & Amoritzation | $5.5M | $7.3M | $7.7M | $6.8M | $7.8M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$4.4M | -$5M | $3.8M | -$567.3K | -$2.3M | |
Change in Inventories | -$5.9M | -$28.9M | $9.8M | $6.7M | -$11.1M | |
Cash From Operations | $35.5M | $21.4M | $31.9M | $46.6M | $31M | |
Capital Expenditures | $4.4M | $13.2M | $3M | $5.5M | $6.4M | |
Cash Acquisitions | -$20.6M | -$8.9M | -- | -$3M | -$26.9M | |
Cash From Investing | -$25M | -$22M | -$2.9M | -$8.4M | -$32M | |
Dividends Paid (Ex Special Dividend) | -$8.1M | -$11.4M | -$11.9M | -$12.9M | -$13.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $22.9M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -$2.1M | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$67.4M | -$22.3M | -$956.9K | $86.8K | |
Cash From Financing | $9.9M | -$17.2M | -$14.4M | -$16.6M | $1.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $20.5M | -$17.8M | $14.7M | $21.5M | $929.6K | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $31.2M | $8.2M | $28.9M | $41.1M | $24.6M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $28M | $24.1M | $16.6M | $19M | $11.1M | |
Depreciation & Amoritzation | $3.1M | $3.5M | $3.4M | $3.5M | $2M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$7.6M | -$3.5M | -$2.7M | -$5M | -$4.1M | |
Change in Inventories | -$11.2M | -$8M | $5.1M | -$3.1M | -$1.2M | |
Cash From Operations | $14.2M | $4M | $19M | $15.8M | $11.3M | |
Capital Expenditures | $6.7M | $2.3M | $1.3M | $3M | $2.1M | |
Cash Acquisitions | -$6.3M | -- | -- | -- | -- | |
Cash From Investing | -$13M | -$2.2M | -$1.2M | -$3M | -$1.9M | |
Dividends Paid (Ex Special Dividend) | -$7.2M | -$6M | -$6.5M | -$6.8M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $4.3M | -- | $1.1K | -- | |
Long-Term Debt Repaid | -- | -- | -$2.2M | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.2K | -$60.7K | -$2.2M | -$19.4K | -$4.2K | |
Cash From Financing | -$8.6M | -$2.1M | -$10.4M | -$8M | -$2.5M | |
Beginning Cash (CF) | $72.1M | $37.4M | $61.5M | $100M | -- | |
Foreign Exchange Rate Adjustment | $145.8K | $877.7K | -$425.3K | $344.6K | -$253.6K | |
Additions / Reductions | -$7.3M | -$323.8K | $7.4M | $4.8M | $6.9M | |
Ending Cash (CF) | $65M | $37M | $68.9M | $104.8M | $55.5M | |
Levered Free Cash Flow | $7.6M | $1.7M | $17.7M | $12.8M | $9.1M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.